ÂÜÀòÂÒÂ×

Mary Sanville is an accomplished scientist with extensive experience in the pharmacokinetics and drug development fields, currently serving as a Scientist IV at Boehringer Ingelheim since August 2008, focusing on the development of Cell Based Neutralizing Antibody Assays for clinical sample analysis. Previously, roles at the same company included Scientist III positions in Biotherapeutics Bioanalysis and Assay Development, where Mary created various assays for drug discovery. Earlier experience includes serving as a Quality Control Analyst and Manufacturing Chemist at Tepnel Lifecodes Corp, along with a tenure as an Adjunct Professor at Housatonic Community College. Educational qualifications include a Master of Science in Chemistry from Sacred Heart University and dual Bachelor's degrees in Cell/Cellular and Molecular Biology and Chemistry from the University of Connecticut.